检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王晓娟[1]
出 处:《中国医药导报》2010年第19期77-78,共2页China Medical Herald
摘 要:目的:探讨爱若华治疗类风湿关节炎的临床疗效及不良反应。方法:治疗组51例采用爱若华治疗,对照组53例采用西乐葆治疗,对两组进行疗效比较观察。结果:治疗组显效率为68.62%,总有效率为90.20%;对照组显效率为35.85%,总有效率为69.81%。治疗组明显优于对照组,差异有统计学意义(P<0.05)。结论:爱若华治疗类风湿关节炎疗效较佳,且副作用较少,安全可靠。Objective:To discuss the clinical efficacy and adverse reactions of Leflunomide in the treatment of rheumatoid arthritis.Methods:51 patients in treatment group were treated with Leflunomide,53 patients in control group were treated with Celebrex,the effects of two groups were compared and observed.Results:In treatment group,the markedly effective rate was 68.62%,the total effective rate was 90.20%;in control group,the markedly effective rate was 35.85%,the total ef fective rate was 69.81%.The treatment group was significantly better than the control group,the difference was statistically significant(P〈0.05).Conclusion:Leflunomide in the treatment of rheumatoid arthritis is better and less side effects,safe and reliable.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.128.24.183